In this study, we conducted a comprehensive bioinformatics analysis of ARPC2 in 33 cancer types based on multiple databases, including gene expression analysis in different tissues and cell lines, gene mutation, DNA methylation, prognostic value and its association with clinical features, TME, tumor immune infiltration cells, and response to ICIs. This evidence concerns the gene ARPC2 and cancer.